Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The negative effect of dexamethasone on calcium-processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder Kim MH; Lee GS; Jung EM; Choi KC; Jeung EBLife Sci 2009[Jul]; 85 (3-4): 146-52AIMS: Although dexamethasone (Dex) is used widely as an anti-inflammatory and immunosuppressive drug, Dex appears to have severe side-effects, including osteoporosis. This study determined the effects of Dex on duodenal and renal expressions of the calcium-processing genes transient receptor potential cation channel, subfamily V, member 5/6 (TRPV5/6), calbindin-D9k/-D28k (CaBP-9k/28k), Na+/Ca2+ exchanger 1 (NCX1), and plasma membrane Ca(2+)-ATPase (PMCA) 1b. MAIN METHODS: Mice were injected subcutaneously with Dex for 1 or 5 days. The mRNA and protein expression levels of these calcium-processing genes were measured by real-time PCR and immunohistochemistry/immunoblot analysis, respectively. In addition, serum parathyroid hormone (PTH) levels were measured following Dex treatments. KEY FINDINGS: Treatment with Dex for 24 h resulted in the inductions of duodenal TRPV6, CaBP-9k and PMCA1b transcripts and renal TRPV5, CaBP-9k, and NCX1 transcripts, while it reduced the transcription of renal TRPV6. Although the expressional changes were weak, duodenal expressions of glucocorticoid receptor (GR), the vitamin D receptor (VDR), and renal expressions of the parathyroid hormone receptor (PTHR) and VDR were increased following 24 h treatment with Dex. A five-day treatment with Dex reduced the transcriptional levels of duodenal TRPV6 and CaBP-9k by 60%. Transcripts for VDR and GR in the duodenum increased marginally. SIGNIFICANCE: These results suggest that the expressions of TRPV6 and CaBP-9k in the duodenum appear to be a major regulatory target for glucocorticoids (GCs), and may be involved in the negative regulation of calcium absorption in GC-induced osteoporosis (GIO). The transcriptional regulation of TRPV6 and CaBP-9k in the duodenum seems complex given that there is an increase at 1-day treatment followed by a decrease at 5-day treatment.|Absorption/drug effects[MESH]|Animals[MESH]|Anti-Inflammatory Agents/*adverse effects[MESH]|Calbindins[MESH]|Calcium Channels/genetics[MESH]|Calcium/blood/*metabolism[MESH]|Dexamethasone/*adverse effects[MESH]|Duodenum/*drug effects/metabolism[MESH]|Gene Expression/drug effects[MESH]|Glucocorticoids/*adverse effects[MESH]|Immunosuppressive Agents/*adverse effects[MESH]|Kidney/*drug effects/metabolism[MESH]|Mice[MESH]|Mice, Inbred ICR[MESH]|Organ Size[MESH]|Parathyroid Glands/anatomy & histology/drug effects[MESH]|Parathyroid Hormone/blood[MESH]|Plasma Membrane Calcium-Transporting ATPases/genetics[MESH]|S100 Calcium Binding Protein G/genetics[MESH]|Sodium-Calcium Exchanger/genetics[MESH]|TRPV Cation Channels/genetics[MESH] |